CA50091-2 - 0x0000000000006960
Males & Females of Non-Childbearing Potential
Energize
* Stipend may pay up to reflected amount.
Start Date:
January 6, 2026 - 1:00pm
End Date:
January 26, 2026 - 7:45am
Study Details
Study Number: CA50091
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $11,250.00
Study Criteria
Age: 19 - 59
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat leukemia.
Route of Administration: Oral
Blood Draws: 31
Study Schedule
Schedule Type: Long Term
Study Length: 20 Night Stay
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 12/15/2025 |
| Tuesday | 12/16/2025 |
| Monday | 12/22/2025 |
| Tuesday | 12/30/2025 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 12/15/2025 |
| Tuesday | 12/16/2025 |
| Monday | 12/22/2025 |
| Tuesday | 12/30/2025 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 1/6/2026 1:00:00 PM | Monday | 1/26/2026 7:45:00 AM | 1 | Lincoln |
